Assignee
GENESIS MOLECULAR TECH INC
US·2 granted patents·1 pending application·0 citations·filing 2021–2023
Top patents by PatentIndex Score
3 records- 0169US12168665B2Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applicationsGENESIS MOLECULAR TECH INC·Filed 2023·Granted Dec 17, 2024·0 cites·15 claims
- 0264US11639356B2Substituted imidazo[1,2-a]pyrazines and pyrazino[1,2-a]pyrimidines as topical agents for dermatological applicationsGENESIS MOLECULAR TECH INC·Filed 2021·Granted May 2, 2023·0 cites·25 claims
- 0363US2023102941A1Topical agents for dermatological applicationsGENESIS MOLECULAR TECH INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →